Clinical Trial: Efficacy and Safety of Serplulimab Combined with Chemotherapy Followed by Cryoablation in Extensive-Stage Small Cell Lung Cancer (China)

China, Oct. 27 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of Serplulimab Combined with Chemotherapy Followed by Cryoablation in Extensive-Stage Small Cell Lung Cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135156

Registration Time: 2026/10/26

Type: Interventional study

Primary Sponsor: Zhongshan Hospital, Fudan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=349312

Published by HT Digital Content Services with permission from Health Daily Digest....